All In MedTech

FDA Clearance Tracker · P200002-S004

EPi-Sense®, EPi-Sense ST™ Guided Coagulation System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 27, 2022 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Dec 27, 2022

Approved

Time to decision

90 days

Received Sep 28, 2022. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P200002-S004
Device name
EPi-Sense®, EPi-Sense ST™ Guided Coagulation System
Applicant location
Mason, OH
Received
Sep 28, 2022
Decided
Dec 27, 2022
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P200002

Device type

Device class
Class III

Every decision under product code OCM

FDA's approval statement

As written in FDA's record.

Approval for the Multifunctional Ablation Generator (MAG) as part of the EPi-Sense® and EPi-Sense ST Guided Coagulation System (EPi-Sense).

Source documents

Other decisions for AtriCure, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.